ATE419837T1 - Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen - Google Patents
Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungenInfo
- Publication number
- ATE419837T1 ATE419837T1 AT06251324T AT06251324T ATE419837T1 AT E419837 T1 ATE419837 T1 AT E419837T1 AT 06251324 T AT06251324 T AT 06251324T AT 06251324 T AT06251324 T AT 06251324T AT E419837 T1 ATE419837 T1 AT E419837T1
- Authority
- AT
- Austria
- Prior art keywords
- granulation method
- producing pharmaceutical
- moist granulation
- aripiprazole compositions
- aripiprazole
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004372 aripiprazole Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000009481 moist granulation Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75670806P | 2006-01-05 | 2006-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE419837T1 true ATE419837T1 (de) | 2009-01-15 |
Family
ID=36637023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06251324T ATE419837T1 (de) | 2006-01-05 | 2006-03-14 | Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen |
Country Status (13)
Country | Link |
---|---|
US (1) | US8865722B2 (de) |
EP (2) | EP2036545A1 (de) |
JP (1) | JP4875001B2 (de) |
CN (1) | CN101351192A (de) |
AT (1) | ATE419837T1 (de) |
CA (1) | CA2627693A1 (de) |
DE (1) | DE602006004694D1 (de) |
DK (1) | DK1808164T3 (de) |
ES (1) | ES2318693T5 (de) |
IL (1) | IL190916A0 (de) |
PL (1) | PL1808164T3 (de) |
PT (1) | PT1808164E (de) |
WO (1) | WO2007081366A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
TR200604349A2 (tr) | 2006-08-15 | 2008-03-21 | NOBEL İLAÇ SANAYii VE TiCARET A.Ş. | Aripiprazol içeren farmasötik bileşimler |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
WO2010079506A2 (en) | 2008-06-23 | 2010-07-15 | Torrent Pharmaceuticals Ltd. | Pharmaceutical composition of aripiprazole |
CA2773003A1 (en) | 2009-09-15 | 2011-03-24 | Ratiopharm Gmbh | Orally disintegrating pharmaceutical dosage form containing aripiprazole |
CN102106826B (zh) * | 2009-12-29 | 2013-06-05 | 上海中西制药有限公司 | 一种阿立哌唑固体制剂及其制备方法 |
WO2011137274A1 (en) * | 2010-04-30 | 2011-11-03 | Bristol-Myers Squibb Company | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
CN102850268B (zh) * | 2011-06-27 | 2015-07-15 | 上海中西制药有限公司 | 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法 |
JO3753B1 (ar) | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
WO2013083674A1 (de) * | 2011-12-08 | 2013-06-13 | Hexal Ag | Neue pharmazeutische statin-zusammensetzung |
WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
WO2013100878A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Pharmaceutical formulations comprising aripiprazole |
WO2013175508A2 (en) | 2012-05-24 | 2013-11-28 | Medreich Limited | Stable pharmaceutical composition of aripiprazole |
JP6007169B2 (ja) * | 2012-11-30 | 2016-10-12 | 大原薬品工業株式会社 | アリピプラゾール無水物を含有する固形製剤の製造方法 |
ES2625613T3 (es) * | 2013-04-30 | 2017-07-20 | Otsuka Pharmaceutical Co., Ltd. | Preparación sólida oral que comprende aripiprazol y método para producir una preparación sólida oral que comprende aripiprazol |
AR096131A1 (es) | 2013-04-30 | 2015-12-09 | Otsuka Pharma Co Ltd | Preparado oral sólido que comprende aripiprazol y un método para producir un preparado oral sólido que comprende aripiprazol |
GR1008442B (el) * | 2014-01-16 | 2015-03-05 | "Φαρματεν Α.Β.Ε.Ε.", | Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης |
EP3002005A1 (de) * | 2014-09-30 | 2016-04-06 | Molkerei Meggle Wasserburg GmbH & Co. Kg | Direktkomprimierter Hilfsstoff auf Basis von Lactose, Cellulose und Stärke |
WO2016189504A1 (en) * | 2015-05-28 | 2016-12-01 | Leiutis Pharmaceuticals Pvt Ltd | Non-lyophilized compositions of aripiprazole and methods of preparation thereof |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA71629C2 (en) | 1999-08-03 | 2004-12-15 | Lilli Icos Llc | Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction |
US20020076437A1 (en) * | 2000-04-12 | 2002-06-20 | Sanjeev Kothari | Flashmelt oral dosage formulation |
CA2311734C (en) | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
TWI324074B (en) | 2001-10-09 | 2010-05-01 | Bristol Myers Squibb Co | Flashmelt oral dosage formulation |
JP2003238393A (ja) | 2002-02-15 | 2003-08-27 | Otsuka Pharmaceut Co Ltd | 施錠性が改善された錠剤及びその製造方法 |
DE10224170A1 (de) * | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
WO2004083183A1 (en) | 2003-03-21 | 2004-09-30 | Hetero Drugs Limited | Novel crystalline forms of aripiprazole |
US20060270683A1 (en) | 2003-04-25 | 2006-11-30 | Lohray Braj B | Polymorphs of aripiprazole |
US20050158383A1 (en) * | 2003-10-21 | 2005-07-21 | Garth Boehm | Quetiapine formulations |
CN1870980B (zh) | 2003-10-23 | 2010-06-23 | 大冢制药株式会社 | 控释无菌阿立哌唑注射剂和方法 |
TW200529850A (en) * | 2003-12-16 | 2005-09-16 | Teva Pharma | Methods of preparing aripiprazole crystalline forms |
EP1715893B8 (de) | 2004-01-20 | 2009-12-16 | Novartis Ag | Direktkomprimierte formulierung und verfahren |
US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
CN101087760B (zh) | 2004-11-18 | 2011-09-28 | 斯索恩有限公司 | 结晶的阿立哌唑溶剂化物 |
EP1812397A1 (de) | 2004-11-18 | 2007-08-01 | Synthon B.V. | Verfahren zur herstellung von kristallinem aripiprazol |
EP1686117A1 (de) | 2005-01-27 | 2006-08-02 | Sandoz AG | Polymorph und Solvate von Aripiprazol |
ES2526415T3 (es) | 2005-03-17 | 2015-01-12 | Synthon B.V. | Comprimidos farmacéuticos de aripiprazol cristalino de tipo II |
WO2007004061A1 (en) | 2005-04-15 | 2007-01-11 | Medichem, S.A. | Syntheses and preparations of polymorphs of crystalline aripiprazole |
US20070014854A1 (en) | 2005-07-15 | 2007-01-18 | Ilan Zalit | Novel granulation process |
US20070014853A1 (en) | 2005-07-15 | 2007-01-18 | Ilan Zalit | Pharmaceutical dosage form containing novel pharmaceutical granulate |
JP2008540644A (ja) | 2005-07-15 | 2008-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | 新規粒質化方法及びそれから生成される粒質物 |
US20070014864A1 (en) | 2005-07-15 | 2007-01-18 | Teva Pharmaceutical Industries, Ltd. | Novel pharmaceutical granulate |
EP1933814A2 (de) | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoteilchenförmige aripiprazol-formulierungen |
JP2008537540A (ja) | 2005-12-22 | 2008-09-18 | テバ ファーマシューティカル インダストリーズ リミティド | アリピプラゾールの粒径を小さくする方法 |
US20070148245A1 (en) | 2005-12-22 | 2007-06-28 | Ilan Zalit | Compressed solid dosage forms with drugs of low solubility and process for making the same |
CN101340896A (zh) | 2005-12-22 | 2009-01-07 | 特瓦制药工业有限公司 | 含有低溶解性药物的压缩的固体剂型和其制备方法 |
US20090054455A1 (en) | 2006-02-03 | 2009-02-26 | Dr. Reddy's Laboratories Ltd. | Aripiprazole co-crystals |
EP1880714A1 (de) | 2006-07-20 | 2008-01-23 | Helm AG | Amorphes Aripiprazol und Verfahren zu dessen Herstellung |
-
2006
- 2006-03-14 WO PCT/US2006/009279 patent/WO2007081366A1/en active Application Filing
- 2006-03-14 EP EP08018220A patent/EP2036545A1/de not_active Withdrawn
- 2006-03-14 DE DE602006004694T patent/DE602006004694D1/de active Active
- 2006-03-14 DK DK06251324T patent/DK1808164T3/da active
- 2006-03-14 JP JP2007558352A patent/JP4875001B2/ja not_active Expired - Fee Related
- 2006-03-14 US US11/376,029 patent/US8865722B2/en active Active
- 2006-03-14 CA CA002627693A patent/CA2627693A1/en not_active Abandoned
- 2006-03-14 CN CNA2006800498824A patent/CN101351192A/zh active Pending
- 2006-03-14 AT AT06251324T patent/ATE419837T1/de not_active IP Right Cessation
- 2006-03-14 ES ES06251324.7T patent/ES2318693T5/es active Active
- 2006-03-14 PL PL06251324T patent/PL1808164T3/pl unknown
- 2006-03-14 PT PT06251324T patent/PT1808164E/pt unknown
- 2006-03-14 EP EP06251324.7A patent/EP1808164B2/de active Active
-
2008
- 2008-04-16 IL IL190916A patent/IL190916A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008531737A (ja) | 2008-08-14 |
US20070154544A1 (en) | 2007-07-05 |
EP1808164B1 (de) | 2009-01-07 |
WO2007081366A1 (en) | 2007-07-19 |
DE602006004694D1 (de) | 2009-02-26 |
PT1808164E (pt) | 2009-03-17 |
US8865722B2 (en) | 2014-10-21 |
ES2318693T5 (es) | 2018-10-04 |
EP2036545A1 (de) | 2009-03-18 |
IL190916A0 (en) | 2008-11-03 |
CN101351192A (zh) | 2009-01-21 |
ES2318693T3 (es) | 2009-05-01 |
JP4875001B2 (ja) | 2012-02-15 |
EP1808164B2 (de) | 2018-07-04 |
CA2627693A1 (en) | 2007-07-19 |
EP1808164A1 (de) | 2007-07-18 |
DK1808164T3 (da) | 2009-04-20 |
PL1808164T3 (pl) | 2009-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419837T1 (de) | Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
DE502007004540D1 (de) | Fertigungslinie zur Herstellung wurstförmiger Produkte | |
NL2000690A1 (nl) | Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine. | |
ATE429906T1 (de) | Trockene aripiprazolformulierungen | |
BRPI0913379A2 (pt) | formulações farmacêuticas sólidas compreendendo bibw 2992 | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
BRPI0820997A2 (pt) | Comprimidos de desintegração oral compreendendo difenidramina. | |
DK1962873T3 (da) | Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier | |
SMT201200014B (it) | Nalmefene cloridrato diidrato. | |
DE112008000701A5 (de) | Zusammensetzung zur Herstellung von Speisern | |
DE602006009764D1 (de) | Terphenylderivate zur Alzheimerbehandlung | |
ATE497493T1 (de) | Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen | |
IL194961A0 (en) | Compounds a-r-x for the manufacture of pharmaceutical preparations | |
ZA200805761B (en) | Pharmaceutical composition for the treatment of nail disease | |
AT503967A3 (de) | Vorrichtung zur herstellung von formteilen | |
PL1853220T3 (pl) | Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne | |
ATE501717T1 (de) | Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms) | |
SMAP200900029A (it) | Stampo assemblabile per produzione di calzature | |
DK2216039T3 (da) | Farmaceutiske sammensætninger til behandling af angst | |
DE602005007319D1 (de) | Zubereitung zur kontinuierlichen Arzneimittelfreisetzung Chitosan enthaltend | |
EA200870236A1 (ru) | Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе | |
ZA200805656B (en) | Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds | |
DE602007011337D1 (de) | Maschine zur Herstellung von Zigarettenfiltern | |
ITBO20060647A1 (it) | Macchina per la produzione di filtri di sigarette. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |